Frontiers in Pharmacology (Mar 2021)

Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update

  • Yiping Lin,
  • Yuke Li,
  • Yuanlian Zeng,
  • Bin Tian,
  • Xiaolan Qu,
  • Qianghua Yuan,
  • Ying Song

DOI
https://doi.org/10.3389/fphar.2021.632767
Journal volume & issue
Vol. 12

Abstract

Read online

Magnolol (MG) is one of the primary active components of Magnoliae officinalis cortex, which has been widely used in traditional Chinese and Japanese herbal medicine and possesses a wide range of pharmacological activities. In recent years, attention has been drawn to this component due to its potential as an anti-inflammatory and antitumor drug. To summarize the new biological and pharmacological data on MG, we screened the literature from January 2011 to October 2020. In this review, we provide an actualization of already known anti-inflammatory, cardiovascular protection, antiangiogenesis, antidiabetes, hypoglycemic, antioxidation, neuroprotection, gastrointestinal protection, and antibacterial activities of MG. Besides, results from studies on antitumor activity are presented. We also summarized the molecular mechanisms, toxicity, bioavailability, and formulations of MG. Therefore, we provide a valid cognition of MG.

Keywords